In vivo regulation of acetylcholine release via adenosine A1 receptor in rat cerebral cortex

Neuroscience Letters

Volumn 209, Issue 3, 1996, Pages 181-184

  Kurokawa, Masako ^a   Shiozaki, Shizuo ^a   Nonaka, Hiromi ^a   Kase, Hiroshi ^a   Nakamura, Joji ^a   Kuwana, Yoshihisa ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

8 Dicyclopropylmethyl 1,3 dipropylxanthine (KF15372); Acetylcholine release; Adenosine A1 receptor; In vivo; Microdialysis; N6 ((R) Phenylisopropyl) adenosine (R PIA)

Indexed keywords

8 DICYCLOPROPYLMETHYL 1,3 DIPROPYLXANTHINE; ACETYLCHOLINE; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; PHENYLISOPROPYLADENOSINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0029885436     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12632-X     Document Type: Article

References (33)

1. Ballarín, M., Fredholm, B.B., Ambrosio, S. and Mahy, N., Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism, Acta Physiol. Scand., 142 (1991) 97-103.
2. 3H]SCH23390, a selective D-1 receptor antagonist ligand, in rat striatum, Life Sci., 35 (1984) 1885-1893.
3. 1 muscarinic receptor subtype between peripheral lung and cerebral cortex demonstrated by the selective antagonist AF-DX 116, Life Sci., 41 (1987) 491-496.
4. 3H]NECA in rat striatal membranes, Mol. Pharmacol., 29 (1986) 331-346.
5. 1 receptors, J. Pharmacol. Exp. Ther., 273 (1995) 637-642.
6. 3H]mepyramine binding of brain membranes, J. Neurochem., 32 (1979) 1653-1663.
7. 3H]acetylcholine from the hippocampus and cerebral cortex of the rat: role of the ectonucleotidases, Eur. J. Neurosci., 6 (1994) 33-42.
8. Damsma, G., Lammerts van Bueren, D., Westerink, B.H.C. and Horn, A.S., Determination of acetylcholine and choline in the fentomole range by means of HPLC, a post-column enzyme reactor, and electrochemical detection, Chromatographia, 24 (1987) 827-831.
9. DeFeudis, F.V., Cholinergic systems and Alzheimer's disease, Drug. Dev. Res., 14 (1988) 95-109.
10. 2 receptors: microdialysis studies in the awake and anaesthetized rat, Neuropharmacology, 33 (1994) 411-421.
11. 2-mediated behavior in short-term reserpinized mice, Eur. J. Pharmacol., 192 (1991) 25-30.
12. Fredholm, B.B. and Dunwiddie, T.V., How does adenosine inhibit transmitter release? Trends Pharmacol. Sci., 9 (1988) 130-134.
13. Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Daly, J.W., Harden, T.K., Jacobson, K.A., Leff, P. and Williams, M., Nomenclature and classification of purinoceptors, Pharmacol. Rev., 46 (1994) 143-156.
14. 3H]PAT, Nature, 305 (1983) 140-142.
15. Greenberg, D.A., U'Prichard, D.C. and Snyder, S.H., Alphanoradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states, Life Sci., 19 (1976) 69-76.
16. 3H]CGS 21680 to rat brain using autoradiography, Neuropharmacology, 34 (1995) 393-403.
17. 2A receptor-mediated modulation of striatal GABA and ACh release, Br. J. Pharmacol., 113 (1994) 43-48.
18. 2a receptor-mediated modulation of striatal acetylcholine release in vivo, J. Neurochem., 66 (1996) 1882-1888.
19. 3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites, J. Neurochem., 36 (1981) 201-219.
20. 2 receptor binding sites, binding properties, brain distribution and functional role, Mol. Pharmacol., 21 (1982) 301-314.
21. Lippiello, P.M. and Fernandes, K.G., Identification of putative high affinity nicotinic receptors on cultured cortical neurons, J. Pharmacol. Exp. Ther., 246 (1988) 409-416.
22. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Sydney, 1986.
23. Pedata, F., Giovannelli, L., Sarno, P.D. and Pepeu, G., Effect of adenosine, adenosine derivatives, and caffeine on acetylcholine release from brain synaptosomes: interaction with muscarinic autoregulatory mechanisms, J. Neurochem., 46 (1986) 1593-1598.
24. Phillis, J.W. and Wu, P.H., The role of adenosine and its nucleotides in central synaptic transmission, Prog. Neurobiol., 16 (1981) 187-239.
25. --evoked acetylcholine release from the in vivo rat cerebral cortex, Brain Res., 605 (1993) 293-297.
26. Phillis, J.W., Perkins, L.M. and O'Regan, M.H., Potassium-evoked efflux of transmitter amino acids and purines from rat cerebral cortex, Brain Res. Bull., 31 (1993) 547-552.
27. 6-((R)-phenylisopropyl)-adenosine-induced cognitive disturbance, J. Med. Chem., 36 (1993) 2508-2518.
28. 3H]dihydroalprenolol binding to beta1-and beta2-noradrenergic receptors in brain, heart, and lung membranes, J. Biol. Chem., 253 (1978) 5090-5102.
29. Verma, A. and Marangos, P.J., Nitrobenzylthioinosine binding in brain: an interspecies study, Life Sci., 36 (1985) 283-290.
30. von Kugelgen, I., Spath, L. and Starke, K. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex, Br. J. Pharmacol., 113 (1994) 815-822.
31. 3H]muscimol, a potent gamma-aminobutyric acid agonist, to rat brain synaptosomal membranes using a filtration assay, J. Neurochem., 32 (1979) 713-718.
32. 3H]cyclopentyladenosine to adenosine A-1 receptors in rat brain membranes, J. Neurochem., 47 (1986) 88-97.
33. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes, J. Neurochem., 50 (1988) 274-281.